244 related articles for article (PubMed ID: 21448847)
1. Lipin 1 gene polymorphisms in polycystic ovary syndrome.
Mlinar B; Ferk P; Pfeifer M; Geršak K; Marc J
Horm Metab Res; 2011 Jun; 43(6):427-32. PubMed ID: 21448847
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients].
Diao XH; Shi YH; Gao Q; Wang LC; Tang R; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):106-9. PubMed ID: 18683748
[TBL] [Abstract][Full Text] [Related]
3. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.
Márquez JL; Pacheco A; Valdés P; Salazar LA
Clin Chim Acta; 2008 Dec; 398(1-2):5-9. PubMed ID: 18722363
[TBL] [Abstract][Full Text] [Related]
4. Association study of +45G15G(T/G) and +276(G/T) polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome.
Li L; Yun JH; Lee JH; Song S; Choi BC; Baek KH
Int J Mol Med; 2011 Feb; 27(2):283-7. PubMed ID: 21125210
[TBL] [Abstract][Full Text] [Related]
5. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
6. Genetic determinants of insulin action in polycystic ovary syndrome.
Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.
Jones MR; Italiano L; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
Fertil Steril; 2006 Nov; 86(5):1438-46. PubMed ID: 17070195
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Akgül C; Uysal M
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):57-60. PubMed ID: 19631445
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome.
Wang K; You L; Shi Y; Wang L; Zhang M; Chen ZJ
Fertil Steril; 2008 Aug; 90(2):378-84. PubMed ID: 17953957
[TBL] [Abstract][Full Text] [Related]
11. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor +405 G/C,-460 T/C and -2578 A/C polymorphisms are not associated with insulin resistance in polycystic ovary syndrome.
Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Uysal M
Int J Immunogenet; 2010 Aug; 37(4):239-43. PubMed ID: 20477880
[TBL] [Abstract][Full Text] [Related]
14. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Yilmaz C
Int J Immunogenet; 2009 Oct; 36(5):283-8. PubMed ID: 19744034
[TBL] [Abstract][Full Text] [Related]
15. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome.
Christopoulos P; Mastorakos G; Gazouli M; Deligeoroglou E; Katsikis I; Diamanti-Kandarakis E; Panidis D; Creatsas G
Ann N Y Acad Sci; 2010 Sep; 1205():185-91. PubMed ID: 20840271
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
Bahceci M; Aydemir M; Tuzcu A
Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
[TBL] [Abstract][Full Text] [Related]
19. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].
Yang Y; Qiao J; Li MZ
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):9-13. PubMed ID: 22455686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
